Hereditary iron and copper deposition

Diagnostics, pathogenesis and therapeutics

Jan Aaseth, Trond Peder Flaten, Ole Andersen

    Research output: Contribution to journalJournal articleResearchpeer-review

    Abstract

    Hereditary deposition of iron (primary haemochromatosis) or copper (Wilson's disease) are autosomal recessive metabolic disease characterized by progressive liver pathology and subsequent involvement of various other organs. The prevalence of primary haemochromatosis is approximately 0.5%, about 200 times higher than the prevalence of Wilson's disease. The two diseases are characterized by homozygous occurrences of mutations in the HFE gene on chromosome 6 (primary haemochromatosis) and the ATP7B gene on chromosome 13 (Wilson's disease). Unlike most other inherited conditions, these diseases can be successfully treated, emphasizing the importance of early diagnosis. Serum ferritin values, transferrin saturation and genetic analysis are used when diagnosing haemochromatosis. The diagnostics of Wilson's disease depends on the use of urinary copper values, serum ceruloplasmin and liver biopsy. If untreated, both of these genetic diseases result in rapidly progressing multiorgan damage and early death. The key treatment for haemochromatosis is phlebotomy, for Wilson's disease chelation or Zn treatment. Although the present treatments considerably improve the prognosis of patients, they may be inadequate in patients diagnosed so late that extensive body deposits of metal have been developed. The main research needs in this field are to further clarify molecular mechanisms of disease progression and to develop new chelators that are more effective and less toxic than those presently available
    Original languageEnglish
    JournalScandinavian Journal of Gastroenterology
    Volume42
    Issue number6
    Pages (from-to)673-681
    Number of pages9
    ISSN0036-5521
    DOIs
    Publication statusPublished - 2007

    Keywords

    • Chelating agents
    • chelation therapy
    • copper
    • diagnosis
    • haemochromatosis
    • hepatolenticular degeneration
    • iron phlebotomy
    • therapy

    Cite this

    Aaseth, Jan ; Flaten, Trond Peder ; Andersen, Ole. / Hereditary iron and copper deposition : Diagnostics, pathogenesis and therapeutics. In: Scandinavian Journal of Gastroenterology. 2007 ; Vol. 42, No. 6. pp. 673-681.
    @article{5eaeae90a3fa11dcaf2d000ea68e967b,
    title = "Hereditary iron and copper deposition: Diagnostics, pathogenesis and therapeutics",
    abstract = "Hereditary deposition of iron (primary haemochromatosis) or copper (Wilson's disease) are autosomal recessive metabolic disease characterized by progressive liver pathology and subsequent involvement of various other organs. The prevalence of primary haemochromatosis is approximately 0.5{\%}, about 200 times higher than the prevalence of Wilson's disease. The two diseases are characterized by homozygous occurrences of mutations in the HFE gene on chromosome 6 (primary haemochromatosis) and the ATP7B gene on chromosome 13 (Wilson's disease). Unlike most other inherited conditions, these diseases can be successfully treated, emphasizing the importance of early diagnosis. Serum ferritin values, transferrin saturation and genetic analysis are used when diagnosing haemochromatosis. The diagnostics of Wilson's disease depends on the use of urinary copper values, serum ceruloplasmin and liver biopsy. If untreated, both of these genetic diseases result in rapidly progressing multiorgan damage and early death. The key treatment for haemochromatosis is phlebotomy, for Wilson's disease chelation or Zn treatment. Although the present treatments considerably improve the prognosis of patients, they may be inadequate in patients diagnosed so late that extensive body deposits of metal have been developed. The main research needs in this field are to further clarify molecular mechanisms of disease progression and to develop new chelators that are more effective and less toxic than those presently available",
    keywords = "Chelating agents, chelation therapy, copper, diagnosis, haemochromatosis, hepatolenticular degeneration, iron phlebotomy, therapy",
    author = "Jan Aaseth and Flaten, {Trond Peder} and Ole Andersen",
    year = "2007",
    doi = "10.1080/00365520601075662",
    language = "English",
    volume = "42",
    pages = "673--681",
    journal = "Scandinavian Journal of Gastroenterology",
    issn = "0036-5521",
    publisher = "Taylor & Francis",
    number = "6",

    }

    Hereditary iron and copper deposition : Diagnostics, pathogenesis and therapeutics. / Aaseth, Jan; Flaten, Trond Peder; Andersen, Ole.

    In: Scandinavian Journal of Gastroenterology, Vol. 42, No. 6, 2007, p. 673-681.

    Research output: Contribution to journalJournal articleResearchpeer-review

    TY - JOUR

    T1 - Hereditary iron and copper deposition

    T2 - Diagnostics, pathogenesis and therapeutics

    AU - Aaseth, Jan

    AU - Flaten, Trond Peder

    AU - Andersen, Ole

    PY - 2007

    Y1 - 2007

    N2 - Hereditary deposition of iron (primary haemochromatosis) or copper (Wilson's disease) are autosomal recessive metabolic disease characterized by progressive liver pathology and subsequent involvement of various other organs. The prevalence of primary haemochromatosis is approximately 0.5%, about 200 times higher than the prevalence of Wilson's disease. The two diseases are characterized by homozygous occurrences of mutations in the HFE gene on chromosome 6 (primary haemochromatosis) and the ATP7B gene on chromosome 13 (Wilson's disease). Unlike most other inherited conditions, these diseases can be successfully treated, emphasizing the importance of early diagnosis. Serum ferritin values, transferrin saturation and genetic analysis are used when diagnosing haemochromatosis. The diagnostics of Wilson's disease depends on the use of urinary copper values, serum ceruloplasmin and liver biopsy. If untreated, both of these genetic diseases result in rapidly progressing multiorgan damage and early death. The key treatment for haemochromatosis is phlebotomy, for Wilson's disease chelation or Zn treatment. Although the present treatments considerably improve the prognosis of patients, they may be inadequate in patients diagnosed so late that extensive body deposits of metal have been developed. The main research needs in this field are to further clarify molecular mechanisms of disease progression and to develop new chelators that are more effective and less toxic than those presently available

    AB - Hereditary deposition of iron (primary haemochromatosis) or copper (Wilson's disease) are autosomal recessive metabolic disease characterized by progressive liver pathology and subsequent involvement of various other organs. The prevalence of primary haemochromatosis is approximately 0.5%, about 200 times higher than the prevalence of Wilson's disease. The two diseases are characterized by homozygous occurrences of mutations in the HFE gene on chromosome 6 (primary haemochromatosis) and the ATP7B gene on chromosome 13 (Wilson's disease). Unlike most other inherited conditions, these diseases can be successfully treated, emphasizing the importance of early diagnosis. Serum ferritin values, transferrin saturation and genetic analysis are used when diagnosing haemochromatosis. The diagnostics of Wilson's disease depends on the use of urinary copper values, serum ceruloplasmin and liver biopsy. If untreated, both of these genetic diseases result in rapidly progressing multiorgan damage and early death. The key treatment for haemochromatosis is phlebotomy, for Wilson's disease chelation or Zn treatment. Although the present treatments considerably improve the prognosis of patients, they may be inadequate in patients diagnosed so late that extensive body deposits of metal have been developed. The main research needs in this field are to further clarify molecular mechanisms of disease progression and to develop new chelators that are more effective and less toxic than those presently available

    KW - Chelating agents

    KW - chelation therapy

    KW - copper

    KW - diagnosis

    KW - haemochromatosis

    KW - hepatolenticular degeneration

    KW - iron phlebotomy

    KW - therapy

    U2 - 10.1080/00365520601075662

    DO - 10.1080/00365520601075662

    M3 - Journal article

    VL - 42

    SP - 673

    EP - 681

    JO - Scandinavian Journal of Gastroenterology

    JF - Scandinavian Journal of Gastroenterology

    SN - 0036-5521

    IS - 6

    ER -